Area’s of poor residential clusters of minorities have highest infection rates….
People living in the poorest New York City neighborhoods are dying from coronavirus at more than double the rate of more affluent neighborhoods, according to new data released by the city’s Health Department.
In zip codes where at least 30 percent of people live in poverty, the death rate from Covid-19 is 232 for every 100,000 people — compared to 100 in low-poverty neighborhoods, where less than 10 percent of the population is poor.
The data is the latest indication of deep disparities in how the coronavirus has affected New York City, the national epicenter of the pandemic. In total, 20,806 New Yorkers have died from the disease.
“This public health emergency has affected all of our communities,” Health Commissioner Oxiris Barbot said in a statement. “This virus is not hitting New Yorkers equitably and that reality is guiding the COVID-19 response.”…
There is already the talk of who will get acmes to virus vaccine shoots as China wants to give their vaccine’s for free and American investor’s are licking their chops about how much money they can make off vaccine’s….Does the vaccine go to place’s Trump wants, like Red states?…Does it go to Blue states that have more infections ?
The promise of a coronavirus vaccine by the end of the year creates a difficult political and public health question: Who gets the vaccine first?
Health care workers would be among the first to receive any vaccine so they can continue to work the pandemic’s front lines. But deciding which groups come next — the elderly, medically vulnerable people, grocery store and meat plant workers, children — is fraught with ethical dilemmas and ripe for political power plays.
Markets soared Monday after Moderna Therapeutics released promising early data on its government-funded vaccine — which means public health agencies will need to rapidly develop a plan for mass production and dissemination of a vaccine. The politics of vaccine distribution could get ugly fast if there aren’t clear rules.
“It absolutely should not be the White House who decides,” said Nicole Lurie, who led the Department of Health and Human Services’ emergency preparedness efforts during the Obama presidency.
But the Trump administration, which will distribute any vaccine that emerges, has already stumbled on the far more modest rollout of the coronavirus drug remdesivir. Government officials have acknowledged that they used flawed data to decide which hospitals would get the first shipments of the scarce drug.
The administration is already trying to ward off shortages and confusion around vaccine distribution by pouring hundreds of millions of dollars into manufacturing the still unproven Moderna shot and another leading candidate from Johnson & Johnson. “Operation Warp Speed” is gearing up for massive manufacturing — all in the U.S. — that will save “years” in production, President Donald Trump said Friday as he introduced the administration’s new vaccine czar, Moncef Slaoui.
“When a vaccine is ready, the U.S. government will deploy every plane, truck and soldier required to help distribute it to the American people as quickly as possible,” Trump said.